ArticleIndian journal of urology : IJU : journal of the Urological Society of India
Benign metastasizing leiomyoma with retroperitoneal lymph node involvement in a patient with a history of renal cell carcinoma.
Article in Indian journal of urology : IJU : journal of the Urological Society of India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benign metastasizing leiomyoma (BML) is thought to arise from either coelomic metaplasia of mesenchymal tissue or peritoneal seeding of uterine fibroid tissue, though its exact etiology is unknown. Herein, we present a 44-year-old Hispanic female with BML identified in the retroperitoneum in the setting of clear cell renal carcinoma. Routine follow-up computed tomography scan, 18 months after a robotic left partial nephrectomy for stage 1 renal tumor, revealed retroperitoneal (para-aortic) adenopathy. Percutaneous biopsy followed by robotic lymph node dissection confirmed the presence of BML. The patient remained asymptomatic with unremarkable imaging and laboratories within a 3-year follow-up.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.